Aristotle University Of Thessaloniki (AUTH)
Σακχαρώδης διαβήτης τύπου 1 και συνεχής καταγραφή γλυκόζης: αξιολόγηση ψυχολογικών παραμέτρων
Abstract
dc:descriptionIntroduction: Type 1 Diabetes Mellitus (T1D) is a genetic autoimmune disorder that gradually leads to a complete lack of insulin in the body. Because of this deficiency, it is necessary to administer insulin exogenously and adopt intensive therapy to prevent possible future complications of the disease. Technological advances are an important ally in the day-to-day management of T1D. In addition to the significant advances in insulin pump technology, recent technological innovations include optimisation and continued development of continuous glucose monitoring (CGM) devices, such as reduction in size, increased accuracy and real-time projection of glucose levels to the user. In the wake of these developments, additional parameters have been formulated to assess T1D management. These include the time glucose levels are in range (70 to 180 mg/dL), the time above range (> 180 mg/dL), the time below range (< 70 mg/dL), and the percentage of the coefficient of variation in glucose levels. Due to the recency of these technological advancements, the body of literature exploring the utilization of real-time CGM devices in conjunction with the adopted method of insulin administration is notably limited. Aims: The aim of the present study was to compare the results of the Sensor-Augmented pump system with the method of multiple daily injections combined with real-time CGM. The comparison will be made in the light of medical-pathological parameters as well as psychological variables. Material-Methods: The study involved voluntary and anonymous participation of adults with T1D who were under the monitoring of the Diabetes Center of the First Propeadeutic Department of Internal Medicine at AHEPA University Hospital. Regarding the medical-pathological parameters, the percentages of time in range, time above range, time below range, mean and standard deviation of sensor glucose levels over the past 14 days were collected. The psychological parameters were evaluated with the questionnaires: World Health Organization Quality of Life-BREF Questionnaire (WHOQOL-BREF), Diabetes Quality of Life Brief Clinical Inventory (DQoL-BCI), Diabetes Distress Scale for Type 1 diabetes (T1-DDS), The Brief Illness Perception Questionnaire (B-IPQ) and Depression Anxiety and Stress Scale 42 (DASS-42).Results: A total of 104 adults with T1D who met the inclusion criteria participated in the study. Among these participants, 63 were using the Sensor-Augmented pump as a treatment method, while the remaining 41 were using multiple daily injections with CGM as a treatment method. The majority of the participants were women, 70 (67.3%), while 34 were men (32.7%). The mean age of the sample was 38.8 (± 11.7) years, with a mean duration of diabetes being 21.4 (± 11.1) years. Participants using the Sensor-Augmented pump system as treatment method showed statistically better results in pathological-medical parameters such as: time in range t(101) = 2.226, p = 0.028, d = 0.44, time below range t(101) = -3.942, p < 0.01, d = 0.87 and in the glycemic variability t(82) = -3.52, p = 0.09, d = 0.72. In contrast, statistically significant differences in favor of the group of people who used as a treatment method the multiple daily injections in combination with CGM emerged in the “psychological health” domain t(102) = -2.345, p = 0.012, d = 0.48 and in the "social relationship" domain t(102) = -2.329, p = 0.017, d = 0.48, of the WHOQOL-BREF questionnaire. Furthermore, the majority of the psychological variables were statistically significantly correlated with the pathological variables, within a range from low to moderate values, leading to either positive or negative correlations. Finally, the parallel mediation analysis revealed a statistically significant mediating effect of "personal control" on the relationship between "anxiety" and "time in range". Conclusions: This PhD thesis aimed to explore the differences between T1D people who used the Sensor-Augmented pump method versus those who applied multiple daily injections combined with real-time CGM. The results showed a superiority of the Sensor-Augmented pump method mainly in the medical-pathological parameters. Meanwhile, the participants in the treatment group using multiple daily injections combined with real-time CGM showed a slight advantage in the psychological variables assessed.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Benioudakis, Emmanouil
- Μπενιουδάκης, Εμμανουήλ
Subjects
dc:subject × 18- Σακχαρώδης διαβήτης τύπου 1
- Γλυκαιμικά αποτελέσματα
- Ψυχολογικά αποτελέσματα
- Συνεχής παρακολούθηση γλυκόζης σε πραγματικό χρόνο
- Ποιότητα ζωής
- Αντλία ινσουλίνης
- Type 1 diabetes mellitus
- Glycaemic outcomes
- Psychological outcomes
- Real-time continuous glucose monitoring
- Quality of life
- Insulin pump
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Clinical Medicine
- Medical and Health Sciences
- Endocrinology, Diabetes and Metabolism
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56799